STUDY ON THE ROLE OF ASPIRIN IN PREVENTING PRETERM BIRTH
Not Applicable
- Conditions
- Health Condition 1: - Health Condition 2: Z00-Z99- Factors influencing health status and contact with health services
- Registration Number
- CTRI/2021/03/031734
- Lead Sponsor
- PGIMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Antenatal Women between 6 to 16 weeks of gestation
Singleton Pregnancy
History of previous spontaneous preterm birth and/or PPROM or history of second trimester abortion
Exclusion Criteria
Previous indicated preterm birth for maternal or fetal reasons
Contraindications to aspirin use
Major fetal malformations in current or previous pregnancy
Multifetal gestation
Moderate /severe anaemia
Medical comorbidities
Uterine anomalies and cervical insufficiency
At risk for preeclampsia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare incidence of preterm birth at less than 37 weeks of gestation between aspirin and non aspirin groupsTimepoint: 9 months
- Secondary Outcome Measures
Name Time Method To compare maternal complications and neonatal outcomes between aspirin and non aspirin groupsTimepoint: 9 months